Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoChange DetectedFebruary 2026 update timestamps were added to the study record, and December 2024 timestamps were removed. These changes reflect administrative updates to the record rather than changes to the study content.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page shows a minor revision update from v3.4.1 to v3.4.2; no substantive content changes are detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision metadata updated from v3.4.0 to v3.4.1, with no visible changes to the study page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page; no study data or eligibility details appear to be affected.SummaryDifference0.0%

- Check83 days agoChange DetectedIndividual location subsections (Alabama Locations, Florida Locations, Georgia Locations, Attica Locations, Sinaloa Locations, Pomeranian Voivodeship Locations, West Yorkshire Locations) were removed and replaced with a consolidated 'Locations' section listing those areas. The page revision tag updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure entry was removed.SummaryDifference0.6%

Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.